colforsin has been researched along with Acute Promyelocytic Leukemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mousavizadeh, K; Noori, S; Pourfathollah, A; Safa, M; Zand, H | 1 |
| Gullberg, U; Lantz, M; Lindvall, L; Olsson, I; Persson, AM | 1 |
| Gullberg, U; Lantz, M; Lindvall, L; Olsson, I | 1 |
| Laskin, DL; Laskin, JD; Robertson, FM; Sirak, AA | 1 |
| Hurme, M; Ronni, T; Serkkola, E; Silvennoinen, O | 1 |
| Mitsuhashi, M; Mitsuhashi, T; Payan, DG | 1 |
6 other study(ies) available for colforsin and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
cAMP protects acute promyelocytic leukemia cells from arsenic trioxide-induced caspase-3 activation and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-Associated Death Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; DNA; G1 Phase Cell Cycle Checkpoints; Humans; Leukemia, Promyelocytic, Acute; Oxides; Proto-Oncogene Mas; Tumor Suppressor Protein p53 | 2014 |
Independent transcriptional and posttranscriptional regulation of the two tumor necrosis factor receptors in promyelocytic HL-60 cells.
Topics: Base Sequence; Bucladesine; Cell Membrane; Colforsin; Cyclic AMP-Dependent Protein Kinases; Cycloheximide; DNA Primers; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Molecular Sequence Data; Oligonucleotides, Antisense; Polymerase Chain Reaction; Protein Kinase C; Receptors, Tumor Necrosis Factor; RNA Processing, Post-Transcriptional; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 1993 |
Modulation of the constitutive gene expression of the 55 kD tumor necrosis factor receptor in hematopoietic cells.
Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Carcinoma, Hepatocellular; Colforsin; Gene Expression Regulation; Humans; Leukemia, Promyelocytic, Acute; Leukocytes, Mononuclear; Liver Neoplasms; Molecular Weight; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Reference Values; RNA; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1990 |
Failure of F-Met-Leu-Phe to induce chemotaxis in differentiated promyelocytic (HL-60) leukemia cells.
Topics: Antigens, Surface; Bucladesine; Butyrates; Cell Differentiation; Cell Division; Chemotaxis, Leukocyte; Colforsin; Dinoprostone; Humans; Hydrogen Peroxide; Leukemia, Promyelocytic, Acute; N-Formylmethionine Leucyl-Phenylalanine; Tumor Cells, Cultured | 1990 |
Control of interleukin-1 beta expression by protein kinase C and cyclic adenosine monophosphate in myeloid leukemia cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Bucladesine; Colforsin; Cyclic AMP; Dinoprostone; Enzyme Activation; Gene Expression; Humans; Interleukin-1; Isoquinolines; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Piperazines; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1990 |
Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells.
Topics: Calcium; Calcium Channel Blockers; Cell Differentiation; Cholera Toxin; Colforsin; Cyclic AMP; Dimethyl Sulfoxide; Dinoprostone; Histamine; Humans; Inositol 1,4,5-Trisphosphate; Isoproterenol; Kinetics; Leukemia, Promyelocytic, Acute; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Histamine H2; Signal Transduction; Tumor Cells, Cultured | 1989 |